Canine hypothyroidism is the most common endocrine disorder in dogs. Understanding its subtle signs, treatment, and welfare implications enables owners to provide compassionate, effective care.
Hypothyroidism welfare impact is insidious because its signs are easily attributed to normal ageing or weight gain rather than a treatable condition. Dogs with hypothyroidism experience genuine welfare compromise: the metabolic slowing causes lethargy that reduces the positive experiences — play, exploration, social interaction — that define good quality of life. Weight gain despite normal feeding causes joint stress and reduces mobility. Skin changes including hair loss, thickening, and seborrhoea cause physical discomfort and are visible welfare indicators. Cold intolerance in affected dogs — who may seek heat sources excessively — indicates thermoregulatory impairment. Treatment with levothyroxine is one of veterinary medicine's most reliably effective interventions: dogs typically show marked improvement within weeks, with return of energy, weight normalisation, and coat improvement over months. Dose titration requires follow-up blood testing at four to eight weeks, and annual monitoring maintains optimal dosing as individual requirements change over time.